Statistics for A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America
Total visits
views | |
---|---|
A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America | 253 |
Total visits per month
views | |
---|---|
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
File Visits
views | |
---|---|
Raje_2018_cost-effectiveness.pdf | 426 |
Top country views
views | |
---|---|
United States | 196 |
Germany | 10 |
Sweden | 7 |
Ukraine | 6 |
India | 4 |
Russia | 4 |
Canada | 3 |
China | 2 |
Spain | 1 |
United Kingdom | 1 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 51 |
Fairfield | 38 |
Houston | 11 |
White Plains | 9 |
Cambridge | 7 |
Jacksonville | 7 |
Kiez | 7 |
Stockholm | 7 |
Kiev | 6 |
San Francisco | 5 |
Ann Arbor | 4 |
Washington | 4 |
Dearborn | 3 |
Gunzenhausen | 3 |
New Delhi | 3 |
Toronto | 3 |
Baltimore | 2 |
Kansas City | 2 |
Miami | 2 |
Ashburn | 1 |
Bartlesville | 1 |
Beijing | 1 |
Black Mountain | 1 |
Brooklyn | 1 |
Costa Mesa | 1 |
Lake Mary | 1 |
Madrid | 1 |
Moscow | 1 |
New York | 1 |
Philadelphia | 1 |
Saint Petersburg | 1 |
Scottsdale | 1 |
Seattle | 1 |
Seremban | 1 |
Sholinganallur | 1 |
West Lafayette | 1 |